Bone loss in Gorham's disease: A case study
- Authors:
- Published online on: January 31, 2013 https://doi.org/10.3892/etm.2013.940
- Pages: 1017-1018
Abstract
Introduction
Gorham’s disease (Gorham-Stout syndrome) is a rare disorder characterized by progressive resorption of the whole or part of a bone (1–5). It is non-hereditary and often occurs in individuals aged <40 years without gender-related differences (6). The pathogenetic mechanism of Gorham’s disease remains unknown. Phase I of this disease represents increased vascular concentration in the bone-displacing fibrous tissues. In phase II, only fibrous tissue is observed (7,8). There is controversy with regard to the presence or absence of osteoclasts in this condition. In certain cases, osteoclastic activity is minimal or non-existent, whereas in other cases, osteoclasts are easily identifiable (9). During the past 10 years, we have identified only 2 cases that were diagnosed as Gorham’s disease. In the current study, we report one of these cases.
Case report
An eight-year-old male in West China was admitted with shortness of breath for 10 months. The patient was admitted to Department of Endocrinology and Metabolism, The Military General Hospital of Beijing PLA, Beijing, on September 13, 2010. Radiographs revealed the absence of the right clavicle, destruction of the anterior extremity of the right ribs and pleural effusion of the right side (Fig. 1A). Bone scanography indicated that the change in the right clavicle was not malignant. The biopsy of the right cervical rib revealed considerable vascular fibrous tissue with certain vessels distending and shunting together to form sinus construction (Fig. 1B), in which there was no endothelial cell proliferation. Masson’s staining revealed the proliferation of collagen.
Acid-fast bacillia and malignant cells were not detected in a sample of pleural effusion; however, the Rivalta and Chyle tests were positive. Other laboratory investigation results were normal, with the exception of low hemoglobin (93 g/l) and a slight elevation of the alkaline phosphatase levels (133 U/l). In the follow-up examination there was no progress of osteolysis of the skull and the other portion of bone. Prior written and informed consent were obtained from every patient and the study was approved by the ethics review board of The Military General Hospital of Beijing PLA.
Discussion
One case of Gorham’s disease was diagnosed according to the clinical manifestations, radiological images and the changes of histopathology. There was no family history of bone disease or trauma. The portions of bone loss were on the rib cage and maxillary bone.
The treatment options utilized previously consist of surgical resection and radiotherapy and mainly target the patient’s symptoms (6,10–14). The disparity of the radio-sensitivity of Gorham’s disease-specific cells has resulted in mixed results following treatment (12–14). In patients with active osteoclasts, anti-resorptive therapy, including bisphosphonates or calcitonin, may improve the progressive osteolytic changes (15–17).
In the current study, radiotherapy was administered to the patient who was identified to have no osteoclasts when examined histologically. Despite the report that >15% of patients succumb due to this disease, the patient was well with no worsening of the condition. The prognosis depends on complications, including neurological deficits and pleural effusion (11,18). Life expectancy is not affected if the extremities are involved.
References
Gorham LW and Stout AP: Massive osteolysis (acute spontaneous absorption of bone, phantom bone, disappearing bone): its relation to hemangiomatosis. J Bone Joint Surg Am. 37:985–1044. 1955.PubMed/NCBI | |
Choma ND, Biscotti CV, Bauer TW, et al: Gorham’s syndrome: a case report and review of the literature. Am J Med. 83:1151–1155. 1987. | |
Jackson J: A boneless arm. Boston Med Surg J. 18:368–369. 1838. | |
Zheng MW, Yang M, Qiu JX, et al: Gorham-Stout syndrome presenting in a 5-year-old girl with a successful bisphosphonate therapeutic effect. Exp Ther Med. 4:449–451. 2012.PubMed/NCBI | |
Al-Jamali J, Glaum R, Kassem A, Voss PJ, Schmelzeisen R and Schön R: Gorham-Stout syndrome of the facial bones: a review of pathogenesis and treatment modalities and report of a case with a rare cutaneous manifestations. Oral Surg Oral Med Oral Pathol Oral Radiol. 114:e23–e29. 2012. View Article : Google Scholar : PubMed/NCBI | |
Hardegger F, Simpson LA and Segmueller G: The syndrome of idiopathic osteolysis. Classification, review and case report. J Bone Joint Surg Br. 67:88–93. 1985.PubMed/NCBI | |
Bruch-Gerharz D, Gerharz CD, Stege H, et al: Cutaneous lymphatic malformations in disappearing bone (Gorham-Stout) disease: A novel clue to the pathogenesis to a rare syndrome. J Am Acad Dermatol. 56:S21–S25. 2007. View Article : Google Scholar : PubMed/NCBI | |
Heffez L, Doku HC, Carter BL, et al: Perspectives of massive osteolysis: report of a case and review of the literature. Oral Surg Oral Med Oral Pathol. 55:331–343. 1983. View Article : Google Scholar : PubMed/NCBI | |
Dickson GR, Mollan RAB and Carr KE: Cytochemical localization of alkaline and acid phosphatase in human vanishing bone disease. Histochemistry. 87:569–572. 1987. View Article : Google Scholar : PubMed/NCBI | |
Picault C, Comtet JJ, Imbert JC, et al: Surgical repair of extensive idiopathic osteolysis of the pelvic girdle (Jackson-Gorham disease). J Bone Jt Surg Br. 66:148–149. 1984. | |
Hejgaard N and Olsen PR: Massive Gorham osteolysis of the right hemipelvis complicated by chylothorax: report of a case in a 9-year-old boy successfully treated by pleurodesis. J Pediatr Orthop. 7:96–99. 1987. | |
Fontanesi J: Radiation therapy in the treatment of Gorham disease. J Pediatr Hematol Oncol. 25:816–817. 2003. View Article : Google Scholar : PubMed/NCBI | |
Dunbar SF, Rosenberg A, Mankin H, et al: Gorham’s massive osteolysis: the role of radiation therapy and a review of the literature. Int J Radiat Oncol Biol Phys. 26:491–497. 1993. | |
Hanly JG, Walsh NM and Bresnihan B: Massive osteolysis in the hand and response to radiotherapy. J Rheumatol. 12:580–582. 1985.PubMed/NCBI | |
Hagberg H, Lamberg K and Astrom G: Alpha-2b interferon and oral clodronate for Gorham’s disease. Lancet. 350:1822–1823. 1997.PubMed/NCBI | |
Hammer F, Kenn W, Wesselmann U, et al: Gorham-Stout disease - stabilization during bisphosphonate treatment. J Bone Miner Res. 20:350–353. 2005. View Article : Google Scholar : PubMed/NCBI | |
Silva S: Gorham-Stout disease affecting both hands: stabilization during biphosphonate treatment. Hand (NY). 6:85–89. 2011. View Article : Google Scholar : PubMed/NCBI | |
Bode-Lesniewska B, von Hochstetter A, Exner GU, et al: Gorham-Stout disease of the shoulder girdle and cervico-thoracic spine: fatal course in a 65-year-old woman. Skeletal Radio. 31:724–729. 2002.PubMed/NCBI |